135 related articles for article (PubMed ID: 17709692)
1. CD20 positive T-cell lymphoma/leukemia: a rare entity with potential diagnostic pitfalls.
Buckner CL; Christiansen LR; Bourgeois D; Lazarchick JJ; Lazarchick J
Ann Clin Lab Sci; 2007; 37(3):263-7. PubMed ID: 17709692
[TBL] [Abstract][Full Text] [Related]
2. Low level CD20 expression on T cell malignancies.
Warzynski MJ; Graham DM; Axtell RA; Zakem MH; Rotman RK
Cytometry; 1994 Jun; 18(2):88-92. PubMed ID: 7523045
[TBL] [Abstract][Full Text] [Related]
3. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
[TBL] [Abstract][Full Text] [Related]
4. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
Chu PG; Loera S; Huang Q; Weiss LM
Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
[TBL] [Abstract][Full Text] [Related]
5. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
[TBL] [Abstract][Full Text] [Related]
6. CD20-positive adult T-cell leukemia.
Yasukawa M; Arai J; Kakimoto M; Sakai I; Kohno H; Fujita S
Am J Hematol; 2001 Jan; 66(1):39-41. PubMed ID: 11426490
[TBL] [Abstract][Full Text] [Related]
7. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
Bittencourt AL; Barbosa HS; Vieira MD; Farré L
Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD20-positive T-cell lymphoma.
Martin B; Stefanato C; Whittaker S; Robson A
J Cutan Pathol; 2011 Aug; 38(8):663-9. PubMed ID: 21623866
[TBL] [Abstract][Full Text] [Related]
9. "Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.
Wu D; Wood BL; Dorer R; Fromm JR
Am J Clin Pathol; 2010 Aug; 134(2):258-65. PubMed ID: 20660329
[TBL] [Abstract][Full Text] [Related]
10. Instability of immunophenotype in plasma cell myeloma.
Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
[TBL] [Abstract][Full Text] [Related]
11. CD20 positive mycosis fungoides: a case report.
Sen F; Kang S; Cangiarella J; Kamino H; Hymes K
J Cutan Pathol; 2008 Apr; 35(4):398-403. PubMed ID: 18261116
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.
Tam CS; Otero-Palacios J; Abruzzo LV; Jorgensen JL; Ferrajoli A; Wierda WG; Lerner S; O'Brien S; Keating MJ
Br J Haematol; 2008 Apr; 141(1):36-40. PubMed ID: 18324964
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating.
Yokote T; Akioka T; Oka S; Hara S; Kobayashi K; Nakajima H; Yamano T; Ikemoto T; Shimizu A; Tsuji M; Hanafusa T
Am J Clin Pathol; 2005 Aug; 124(2):199-204. PubMed ID: 16040289
[TBL] [Abstract][Full Text] [Related]
14. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
[TBL] [Abstract][Full Text] [Related]
15. Refractory T cell acute lymphoblastic leukemia with unusual karyotype and interesting immunophenotype.
Anreder MB; Mitruka BM; Gill J; Varela M; Rozans MK; Krause JR
J La State Med Soc; 1996 Dec; 148(12):521-4. PubMed ID: 8990795
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
[TBL] [Abstract][Full Text] [Related]
17. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
18. CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma.
Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Fosmire SP; Coffey D; Bellgrau D; Modiano JF
Vet Pathol; 2005 Jul; 42(4):468-76. PubMed ID: 16006606
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
[TBL] [Abstract][Full Text] [Related]
20. Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells.
Müller T; Uherek C; Maki G; Chow KU; Schimpf A; Klingemann HG; Tonn T; Wels WS
Cancer Immunol Immunother; 2008 Mar; 57(3):411-23. PubMed ID: 17717662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
